AAAAAA
Results:
1-8
|
Results: 8
Authors:
ALDENKAMP AP
BAKER G
PIETERS MSM
SCHOEMAKER HC
COHEN AF
SCHWABE S
Citation: Ap. Aldenkamp et al., THE NEUROTOXICITY SCALE - THE VALIDITY OF A PATIENT-BASED SCALE, ASSESSING NEUROTOXICITY, Epilepsy research, 20(3), 1995, pp. 229-239
Authors:
SAANO V
SCHURREISINGER S
MOBIUS HJ
MENGE G
EZZET F
ANDERSSON P
SCHWABE S
Citation: V. Saano et al., EFFECT OF OXCARBAZEPINE ON ANTIPYRINE METABOLISM IN HEALTHY-VOLUNTEERS, Epilepsia, 36, 1995, pp. 161-161
Authors:
BROOKMAN LJ
LLOYD P
LECAILLON JB
EZZET F
ROUTLEDGE PA
SCHWABE S
Citation: Lj. Brookman et al., SINGLE-CENTER, OPEN-LABEL, PLACEBO-CONTROLLED TRIAL TO DETERMINE THE EFFECTS OF 900 MG OXCARBAZEPINE TWICE-DAILY ON MARKERS OF ENZYME-INDUCTION IN HEALTHY MALE-VOLUNTEERS, Epilepsia, 36, 1995, pp. 161-161
Authors:
SCHWABE S
Citation: S. Schwabe, OXCARBAZEPINE - CLINICAL DEVELOPMENT PROGRAM, Epilepsia, 35, 1994, pp. 190000051-190000053
Authors:
SCHWABE S
Citation: S. Schwabe, CLINICAL DEVELOPMENT OUTLOOK OF OXCARBAZEPINE, Epilepsia, 35, 1994, pp. 190000002-190000004
Authors:
ANDERMANN F
SCHWABE S
MCLEAN MJ
LLOYD P
BARUZZI A
Citation: F. Andermann et al., OXCARBAZEPINE - EXPERIENCE AND FUTURE-ROLE - PANEL DISCUSSION .1., Epilepsia, 35, 1994, pp. 190000020-190000020
Authors:
ANDERMANN F
SCHWABE S
GRAM L
DAM M
ANDERMANN E
DULAC O
REMILLARD G
Citation: F. Andermann et al., OXCARBAZEPINE - EXPERIENCE AND FUTURE-ROLE - PANEL DISCUSSION .2., Epilepsia, 35, 1994, pp. 190000030-190000030
Authors:
VANAMELSVOORT T
BAKSHI R
DEVAUX CB
SCHWABE S
Citation: T. Vanamelsvoort et al., HYPONATREMIA ASSOCIATED WITH CARBAMAZEPINE AND OXCARBAZEPINE THERAPY - A REVIEW, Epilepsia, 35(1), 1994, pp. 181-188
Risultati:
1-8
|